| Preview | Issue Date | Title / Name | Author(s) | Type |
 | Jul-2022 | Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma | Bhave, Prachi; Ahmed, Tasnia; Lo, Serigne N.; Shoushtari, Alexander; Zaremba, Anne, et al | Journal Article | |
| Jan-2023 | Immune and genomic biomarkers of immunotherapy response in cancer of unknown primary | Posner, Atara; Sivakumaran, Tharani; Pattison, Andrew; Etemadmoghadam, Dariush; Thio, Niko, et al | Journal Article | |
| 2021 | MO01.39 Liposomal Irinotecan in Adults with Small Cell Lung Cancer who Progressed on Platinum-Based Therapy: Subgroup Analyses by Platinum Sensitivity | Spigel, David R.; Paz-Ares, Luis G.; Chen, Yuanbin; Jove, Maria; Juan-Vidal, Oscar, et al | Conference Paper | |
| 2019 | OA03.03 Initial Efficacy and Safety Results of Irinotecan Liposome Injection (nal-IRI) in Patients with Small Cell Lung Cancer | Paz-Ares Rodriguez, L.; Spigel, David R.; Chen, Yuanbin; Jove, Maria; Juan, O., et al | Conference Paper | |
| 18-Nov-2024 | Real-world impact of pembrolizumab availability for deficient mismatch repair metastatic colorectal cancer | Loft, Matthew; Wong, Vanessa; Kosmider, Suzanne; Wong, Rachel; Shapiro, Jeremy, et al | Journal Article | |
| 2022 | Regional Victorian trials alliance: Linkages, Innovation, Special populations, Equity (ReViTALISE) project: Addressing disparity in regional populations | Long, Donna; Collins, Ian M.; Harris, Samuel; Torres, Javier; Faisal, Wasek, et al | Conference Paper | |
| 2020 | RESILIENT part I, an open-label, safety run-in of liposomal irinotecan in adults with small cell lung cancer (SCLC) who have progressed with platinum-based first-line (1L) therapy: Subgroup analyses by platinum sensitivity | Spigel, David R.; Paz-Ares, Luis G.; Chen, Yuanbin; Jove, Maria; Juan-Vidal, Oscar, et al | Conference Paper | |
| 2019 | Wither surgical oncology? | Pham, Toan D.; Narasimhan, Vignesh; Guerra, Glen; Kong, Joseoh; Desai, Jayesh, et al | Journal Article | |
